A20 Cells

The A20 cell line is derived from a reticulum cell sarcoma in a mouse and is widely used in immunology and cancer research. Reticulum cell sarcoma is a type of B-cell lymphoma, and A20 cells provide a valuable model for studying the biology of B-cell lymphomas and the immune response. These cells are particularly useful for investigating the mechanisms of B-cell development, activation, signaling, and the interaction between tumor cells and the immune system. Additionally, A20 cells play a crucial role in research focused on the production and function of cytokines, which are essential for immune regulation. A20 cells display a lymphoblastic morphology and express surface markers typical of B-cells, including surface immunoglobulin and major histocompatibility complex (MHC) molecules. Researchers utilize A20 cells to study antigen presentation, B-cell receptor signaling, and the role of various cytokines in immune responses. These cells are also instrumental in the development and testing of immunotherapies, such as monoclonal antibodies and checkpoint inhibitors, aimed at treating B-cell lymphomas and other hematological malignancies. Additionally, A20 cells serve as a model for evaluating the efficacy and safety of novel therapeutic agents in preclinical studies. The utility of A20 cells in immunological research and the understanding of B-cell pathophysiology highlights their importance in advancing cancer research and developing new treatment strategies.